GB Meka
Stocks to watch

THC

Compare

TENET HEALTHCARE CORP · Healthcare

$257.48
▼ 0.0%Close 2026-09-30

Live intraday price

Compare with our price levels

T2283.05
T1270.61
E1244.44
E3212.61
SL205.02

Close 2026-09-30: $257.48 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▲ Leaning positive

Not in the buy zone yet — needs to drop 5.1% · 2 whales recently bought

1 month
▼ 3.2%
3 months
▲ 34.7%
1 year
▲ 28.0%
Analyst target
$284.64 +10.5%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$244.44 -5.1%
E2$228.48 -11.3%
E3$212.61 -17.4%
Targets
T1$270.61 5.1%
T2$283.05 9.9%
T3$298.23 15.8%
Stop-loss
SL$205.02 -20.4%
Whale cost ~$204.21 -20.7%

Risk : reward 1 : 2.3Moves ~$7.59 a day

⚖️ Positives and risks

✓ Positives (4)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 2 ราย
  • ●แนวโน้มระยะยาวเป็นขาขึ้น (เหนือ MA200 และ MA200 ชี้ขึ้น)
  • ●แข็งแกร่งกว่าตลาด (S&P 500) +18% ใน 6 เดือน
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
! Risks (1)
  • ●เซียนขายออก/ลดสัดส่วน 1 ราย: Stephen Mandel (ขายหมด)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

KERREY J ROBERT · Director

2026-09-14 · 5,483 shares @ $263.04

$1M
Sell

KERREY J ROBERT · Director

2026-09-14 · 4,025 shares @ $264.10

$1M
Sell

KERREY J ROBERT · Director

2026-09-14 · 2,502 shares @ $264.62

$662,079
Sell

MARK RICHARD J · Director

2026-09-10 · 10,000 shares @ $263.42

$3M
Sell

West Nadja · Director

2026-09-02 · 1,152 shares @ $258.80

$298,138
Sell

Foo Lisa Y · COO

2026-08-31 · 24,000 shares @ $266.32

$6M
Sell

Sutaria Saumya · CEO · Director

2026-08-25 · 24,881 shares @ $274.10

$7M
Sell

Sutaria Saumya · CEO · Director

2026-08-25 · 17,220 shares @ $273.34

$5M
Sell

Sutaria Saumya · CEO · Director

2026-08-25 · 7,899 shares @ $275.26

$2M
Sell

Sutaria Saumya · CEO · Director

2026-08-24 · 36,656 shares @ $278.90

$10M
Sell

Sutaria Saumya · CEO · Director

2026-08-24 · 13,344 shares @ $278.17

$4M
Sell

HANEY CECIL D · Director

2026-08-24 · 1,300 shares @ $278.03

$361,439
Sell

Romo Tammy · Director

2026-08-07 · 2,500 shares @ $260.83

$652,075
Sell

Romo Tammy · Director

2026-08-06 · 4,922 shares @ $264.15

$1M
Sell

Blunt Roy · Director

2026-08-05 · 600 shares @ $262.68

$157,608

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$20.9B
Next earnings2026-10-27
P/E (price to earnings)10.0
Forward P/E (on expected earnings)12.3
Revenue growth (YoY)+6.8%
Earnings growth (YoY)+213.4%
Net profit margin+10.3%
ROE+37.3%
Debt to equity (D/E)152%
Dividend yield-
Analyst targets (high / low)$315.00 / $260.00
Number of analysts22
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Sideways → · Uptrend ↗
RSI48
MA50 / MA200$259.41 / $212.91
Distance from MA200+20.9%
MACDNegative
1-year high / low$283.05 / $157.58
vs. S&P 500 (6 months)+17.7%
Volume vs. average0.09×